This content is only available within our institutional offering.

01 Jul 2022
LIBERUM: Morning Comment

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
LIBERUM: Morning Comment
Oxford BioMedica plc (OXB:LON), 614 | Braemar PLC (BMS:LON), 240 | ReNeuron Group plc (RNUGF:OTC), 0
- Published:
01 Jul 2022 -
Author:
Panmure Liberum Research Team -
Pages:
4 -